117 related articles for article (PubMed ID: 37449671)
1. Scoparone attenuates glioma progression and improves the toxicity of temozolomide by suppressing RhoA/ROCK1 signaling.
Zhou Y; Han Z; Zhao Z; Zhang J
Environ Toxicol; 2024 Feb; 39(2):562-571. PubMed ID: 37449671
[TBL] [Abstract][Full Text] [Related]
2. Sevoflurane Inhibits Glioma Cells Proliferation and Metastasis through miRNA-124-3p/ROCK1 Axis.
Gao C; Shen J; Meng ZX; He XF
Pathol Oncol Res; 2020 Apr; 26(2):947-954. PubMed ID: 30915607
[TBL] [Abstract][Full Text] [Related]
3. Silencing Drp1 inhibits glioma cells proliferation and invasion by RHOA/ ROCK1 pathway.
Yin M; Lu Q; Liu X; Wang T; Liu Y; Chen L
Biochem Biophys Res Commun; 2016 Sep; 478(2):663-8. PubMed ID: 27495873
[TBL] [Abstract][Full Text] [Related]
4. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
5. Sevoflurane suppresses glioma tumorigenesis via regulating circ_0079593/miR-633/ROCK1 axis.
Cheng S; Cheng J
Brain Res; 2021 Sep; 1767():147543. PubMed ID: 34089702
[TBL] [Abstract][Full Text] [Related]
6. Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway.
Li N; Yang F; Liu DY; Guo JT; Ge N; Sun SY
World J Gastrointest Oncol; 2021 Sep; 13(9):1164-1183. PubMed ID: 34616521
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Rho-associated protein kinase 1 suppresses proliferation and invasion of glioma cells.
Zhang P; Lu Y; Liu XY; Zhou YH
Tumour Biol; 2015 Jan; 36(1):421-8. PubMed ID: 25266804
[TBL] [Abstract][Full Text] [Related]
8. Schisandrin B inhibits tumor progression of hepatocellular carcinoma by targeting the RhoA/ROCK1 pathway.
Yang H; Wu T
J Gastrointest Oncol; 2023 Apr; 14(2):533-543. PubMed ID: 37201042
[TBL] [Abstract][Full Text] [Related]
9. The cyclohexene derivative MC-3129 exhibits antileukemic activity via RhoA/ROCK1/PTEN/PI3K/Akt pathway-mediated mitochondrial translocation of cofilin.
Zheng Y; Ouyang Q; Fu R; Liu L; Zhang H; Hu X; Liu Y; Chen Y; Gao N
Cell Death Dis; 2018 May; 9(6):656. PubMed ID: 29844397
[TBL] [Abstract][Full Text] [Related]
10. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
11. Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression.
Huang Y; Xue B; Pan J; Shen N
Exp Mol Pathol; 2021 Jun; 120():104637. PubMed ID: 33844975
[TBL] [Abstract][Full Text] [Related]
12. FHOD3 promotes carcinogenesis by regulating RhoA/ROCK1/LIMK1 signaling pathway in medulloblastoma.
Yu J; Shi W; Zhao R; Shen W; Li H
Clin Transl Oncol; 2020 Dec; 22(12):2312-2323. PubMed ID: 32447646
[TBL] [Abstract][Full Text] [Related]
13. Actein induces apoptosis in leukemia cells through suppressing RhoA/ROCK1 signaling pathway.
Zhou WD; Wang X; Sun XZ; Hu J; Zhang RR; Hong Z
Int J Oncol; 2017 Dec; 51(6):1831-1841. PubMed ID: 29039493
[TBL] [Abstract][Full Text] [Related]
14. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
15. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway.
Yan L; Li H; An W; Wei W; Zhang X; Wang L
Bioengineered; 2021 Dec; 12(1):5850-5858. PubMed ID: 34486491
[TBL] [Abstract][Full Text] [Related]
16. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
17. Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway.
Fei YQ; Shi RT; Zhou YF; Wu JZ; Song Z
Neurochem Int; 2022 Jul; 157():105348. PubMed ID: 35490896
[TBL] [Abstract][Full Text] [Related]
18. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition.
Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X
Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969
[TBL] [Abstract][Full Text] [Related]
19. RhoA/ROCK/PTEN signaling is involved in AT-101-mediated apoptosis in human leukemia cells in vitro and in vivo.
Li G; Liu L; Shan C; Cheng Q; Budhraja A; Zhou T; Cui H; Gao N
Cell Death Dis; 2014 Jan; 5(1):e998. PubMed ID: 24434521
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
Ma S; Fu T; Zhao S; Gao M
Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
